Cargando…

Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia

Chronic pain is one of the most common causes of the need for clinical evaluation, acquiring more importance in the elderly with cognitive impairment. Reduced self-reporting capabilities cause unrelieved pain contributing to the development of agitation. Safe and effective pain treatment can afford...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scuteri, Damiana, Rombolà, Laura, Hayashi, Takafumi, Watanabe, Chizuko, Sakurada, Shinobu, Hamamura, Kengo, Sakurada, Tsukasa, Tonin, Paolo, Bagetta, Giacinto, Morrone, Luigi A., Corasaniti, Maria Tiziana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370288/ https://www.ncbi.nlm.nih.gov/pubmed/35956935 http://dx.doi.org/10.3390/molecules27154987

Ejemplares similares

Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia
por: Scuteri, Damiana, et al.
Publicado: (2021)

Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent
por: Rombolà, Laura, et al.
Publicado: (2020)

Efficacy of Essential Oils in Pain: A Systematic Review and Meta-Analysis of Preclinical Evidence
por: Scuteri, Damiana, et al.
Publicado: (2021)

Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions
por: Scuteri, Damiana, et al.
Publicado: (2022)

Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy
por: Scuteri, Damiana, et al.
Publicado: (2022)

Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach
por: Scuteri, Damiana, et al.
Publicado: (2019)

Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues
por: Rombolà, Laura, et al.
Publicado: (2022)

Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats
por: Rombolà, Laura, et al.
Publicado: (2019)

Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats
por: Rombolà, Laura, et al.
Publicado: (2017)

Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms
por: Scuteri, Damiana, et al.
Publicado: (2017)

Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation”
por: Scuteri, Damiana, et al.
Publicado: (2021)

Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia
por: Scuteri, Damiana, et al.
Publicado: (2022)

Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8
por: Hayashi, Takafumi, et al.
Publicado: (2020)

Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice
por: Scuteri, Damiana, et al.
Publicado: (2020)

Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation
por: Hamamura, Kengo, et al.
Publicado: (2020)

Exploitation of Thermal Sensitivity and Hyperalgesia in a Mouse Model of Dystonia
por: Scuteri, Damiana, et al.
Publicado: (2021)

Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance
por: Rombolà, Laura, et al.
Publicado: (2020)

Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis
por: Corasaniti, Maria Tiziana, et al.
Publicado: (2023)

Effect of Gabapentin in a Neuropathic Pain Model in Mice Overexpressing Human Wild-Type or Human Mutated Torsin A
por: Scuteri, Damiana, et al.
Publicado: (2021)

Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double‐blind, placebo‐controlled trial to assess the efficacy of furocoumarin‐free bergamot loaded in a nanotechnology‐based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia
por: Scuteri, Damiana, et al.
Publicado: (2021)

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
por: Scuteri, Damiana, et al.
Publicado: (2019)

Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis
por: Scuteri, Damiana, et al.
Publicado: (2023)

Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) Pain Scale: Study Protocol
por: Scuteri, Damiana, et al.
Publicado: (2022)

Opioids Resistance in Chronic Pain Management
por: Morrone, Luigi A., et al.
Publicado: (2017)

Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
por: Scuteri, Damiana, et al.
Publicado: (2021)

Dementia and COVID-19: A Case Report and Literature Review on Pain Management
por: Scuteri, Damiana, et al.
Publicado: (2022)

Pattern of triptans use: a retrospective prescription study in Calabria, Italy
por: Scuteri, Damiana, et al.
Publicado: (2020)

Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis
por: Scuteri, Damiana, et al.
Publicado: (2020)

Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia
por: Scuteri, Damiana, et al.
Publicado: (2020)

Pain Assessment and Treatment in Dementia at the Time of Coronavirus Disease COVID-19
por: Scuteri, Damiana, et al.
Publicado: (2020)

Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy
por: Scuteri, Damiana, et al.
Publicado: (2019)

Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine
por: Scuteri, Damiana, et al.
Publicado: (2022)

Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Corasaniti, Maria Tiziana, et al.
Publicado: (2023)

ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development
por: Pignolo, Loris, et al.
Publicado: (2022)

Aromatherapy in Stroke Patients: Is it Time to Begin?
por: Contrada, Marianna, et al.
Publicado: (2021)

Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab
por: Scuteri, Damiana, et al.
Publicado: (2021)

Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
por: Adornetto, Annagrazia, et al.
Publicado: (2020)

Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy
por: Scuteri, Damiana, et al.
Publicado: (2018)

Airless bodies of the inner solar system: understanding the process affecting rocky, airless surfaces
por: Grier, Jennifer A, et al.
Publicado: (2018)

Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence
por: Scuteri, Damiana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h93r9nao0chl8p7sochk1i6a0u